Aquestive Therapeutics, Inc. - SIC # 2834 - PHARMACEUTICAL PREPARATIONS

Ticker Exchange SIC # Website Latest Ticker
AQST Nasdaq 2834 www.aquestive.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Aquestive Therapeutics, Inc.

Aquestive Therapeutics price target lowered to $6 from $8 at Lake Street - Feb 4th, 2026 6:46 am
Aquestive Therapeutics, Inc. (NASDAQ:AQST) Analysts Just Trimmed Their Revenue Forecasts By 26% - Feb 4th, 2026 5:46 am
Leerink sees ‘silver lining’ in Aquestive CRL given defined path to approval - Feb 3rd, 2026 8:45 am
Does Aquestive Therapeutics (AQST) FDA Packaging Setback Reframe the Risk‑Reward in Its Allergy Franchise? - Feb 3rd, 2026 5:10 am
Aquestive receives FDA CRL for Anaphylm allergic reaction treatment - Feb 3rd, 2026 3:50 am
Health Care Roundup: Market Talk - Feb 2nd, 2026 3:17 pm
Aquestive Therapeutics Gets FDA CRL for Anaphylm, Eyes Q3 Resubmission After Human Factors Fixes - Feb 2nd, 2026 10:52 am
Aquestive Therapeutics Announces FDA Issuance of Complete Response Letter for Anaphylm™ - Feb 2nd, 2026 5:00 am
Jim Cramer on Aquestive Therapeutics: “I’m Not Sure If They Deserve the Benefit of the Doubt” - Jan 22nd, 2026 1:09 am
Here's Why Aquestive Therapeutics (AQST) Is a Great 'Buy the Bottom' Stock Now - Jan 14th, 2026 7:55 am
Down 37% in 4 Weeks, Here's Why Aquestive Therapeutics (AQST) Looks Ripe for a Turnaround - Jan 12th, 2026 7:35 am
Assessing Aquestive Therapeutics (AQST) Valuation After FDA Flags Anaphylm Application Deficiencies - Jan 11th, 2026 10:10 am
Why Aquestive Therapeutics (AQST) Is Down 39.4% After FDA Flags Deficiencies In Anaphylm Application – And What's Next - Jan 10th, 2026 9:05 am
Morning Movers: Oklo, Vistra climb following Meta nuclear energy deals - Jan 10th, 2026 7:00 am
Sector Update: Health Care Stocks Decline Late Afternoon - Jan 9th, 2026 1:59 pm
Aquestive Therapeutics Announces Regulatory Development for Anaphylm™ (dibutepinephrine) Sublingual Film and Provides Business Update - Jan 9th, 2026 5:00 am
Aquestive Therapeutics (AQST) Upgraded to Buy: Here's Why - Jan 7th, 2026 10:00 am
Breakeven On The Horizon For Aquestive Therapeutics, Inc. (NASDAQ:AQST) - Jan 6th, 2026 3:59 am
Looking at the Narrative for Aquestive Therapeutics After New Anaphylm Patents and FDA Momentum - Dec 7th, 2025 10:04 pm
Aquestive Therapeutics to Participate in the Piper Sandler 37th Annual Healthcare Conference - Nov 24th, 2025 5:00 am